22157.jpg
Global Non-Viral Transfection Reagents and Systems Market 2023 to 2035: Featuring Genprex, Inovio Pharmaceuticals, MaxCyte, MilliporeSigma, Nepa Gene and OZ Biosciences Among Others
16 mars 2023 06h38 HE | Research and Markets
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents and Systems Market (2nd Edition) by Type of Non-Viral Transfection Method, End-User, Application Areas and Key...
PCI logo from eps file.jpg
PCI Biotech to present at the 9th International mRNA Health Conference
09 nov. 2021 03h30 HE | PCI Biotech Holding ASA
Oslo (Norway), 9 November 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced...
22157.jpg
2021 Insights on the RNA Therapeutics Global Market - Stability of mRNA Vaccines and RNA Therapeutics at Ambient Temperature Presents Opportunities
15 juil. 2021 05h23 HE | Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "RNA Therapeutics: Global Technology Growth Opportunities, 2021" report has been added to ResearchAndMarkets.com's offering. RNA therapeutics is a...
PCI logo from eps file.jpg
PCI Biotech to present at European Biotech Investor Days 2021
06 avr. 2021 06h30 HE | PCI Biotech Holding ASA
Oslo (Norway), 6 April 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced that...
PCI logo from eps file.jpg
PCI Biotech to present at RNA Therapeutics Virtual Conference
22 janv. 2021 06h04 HE | PCI Biotech Holding ASA
Oslo (Norway), 22 January 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced...